← Back to Clinical Trials
Recruiting NCT04829617

Promoting Well-being and Health in Heart Failure

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Heart Failure
Sponsor Massachusetts General Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 280
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-11-29
Completion 2027-06-30
Interventions
PP-MI InterventionMI-alone Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The focus of this study is to test the efficacy of a 12-week, phone-delivered Positive Psychology-Motivational Interviewing (PP-MI) intervention, with additional twice weekly PP and health behavior text messages for a total of 24 weeks (with interactive, algorithm-driven, goal-focused text messages in the final 12 weeks), compared to an attention-matched MI-based educational condition, in a randomized trial (NIH Stage II) of 280 patients with New York Heart Association class I-III Heart Failure (HF).

Eligibility Criteria

Inclusion Criteria: * Adult patients with NYHA class I, II, or III HF. * Suboptimal adherence to health behaviors. This will be defined as a total score of ≤15 on three Medical Outcomes Study Specific Adherence Scale (MOS) items regarding diet/exercise/medications. Exclusion Criteria: * Cognitive deficits impeding a participant's ability to provide informed consent or participate, assessed via a 6-item cognitive test. * Medical conditions likely to lead to death within 6 months. * Inability to participate in physical activity due to another medical condition (e.g., arthritis). * Inability to read, write, or speak in English. * Current participation in another intervention or program that has been designed to promote well-being or health behavior adherence.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}